Oppenheimer Asset Management’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$202K Sell
7,126
-531
-7% -$15.1K ﹤0.01% 1096
2025
Q1
$226K Buy
+7,657
New +$226K ﹤0.01% 1025